Accessing this medication in the United States can be a considerable hurdle for some patients affected by hereditary tyrosinemia type 1. This rare disease status has resulted in a high cost , limiting https://robertfsqc620648.blogdigy.com/nitisinone-in-the-usa-access-and-availability-67405072